HOME › Press Releases › Veterinary Diagnostics Market worth 6.71 Billion USD by 2021
Veterinary Diagnostics Market worth 6.71 Billion USD by 2021
The report "Veterinary Diagnostics Market by Product (Instruments, Consumables, Services) by Technology (Diagnostic Imaging, Clinical Chemistry, Immunodiagnostics, Molecular Diagnostics) by Animal (Dogs, Cats, Horses, Cattle, Pigs, Poultry) - Global forecast to 2021", analyzes and studies the major market drivers, restraints, and opportunities in North America, Europe, Asia-Pacific, and Rest of the World.
Browse 305 market data Tables and 40 Figures spread through 306 Pages and in-depth TOC on "Veterinary Diagnostics Market by Product (Instruments, Consumables, Services) by Technology (Diagnostic Imaging, Clinical Chemistry, Immunodiagnostics, Molecular Diagnostics) by Animal (Dogs, Cats, Horses, Cattle, Pigs, Poultry) - Global forecast to 2021"
Early buyers will receive 10% customization on reports.
The veterinary diagnostics market witnessed healthy growth during the last decade and is expected to grow at a CAGR of 8.6% between 2016 and 2021 to reach 6.71 Billion by 2021. The growth in this market is majorly attributed to factors such as rising animal healthcare expenditure, rising pet adoption, growing demand for animal-derived food products, increasing number of veterinary practitioners and their growing income levels in developed regions, increasing demand for pet insurance, and rising awareness about zoonotic diseases.
The global veterinary diagnostics market is segmented based on product, technology, animal, and geography. Based on product type, the market is segmented into consumables, instruments, and services. Based on technology, the market is segmented into diagnostic imaging, clinical chemistry, immunodiagnostics, hematology, and molecular diagnostics. Based on animal type, the market is segmented into companion animals and food-producing animals. The food-producing animals segment is further segmented into cattle, pigs, sheep and goats, poultry, and other food-producing animals. On the basis of end-users, the global veterinary diagnostics market is segmented into reference laboratories, veterinary hospitals and clinics, point-of-care testing/ in-house testing, and research institutes. Similarly, on the basis of geography, the veterinary diagnostics market is segmented into Europe, North-America, Asia-Pacific, and Rest of the World.
In 2015, diagnostic imaging accounted for the largest share of the global veterinary diagnostics market. However, immunodiagnostics segment is expected to witness the highest growth over the next five years. The high growth in this segment can be attributed to the advantages such as easy handling, high sensitivity, accuracy, and rapid diagnosis offered by the lateral flow tests and ELISA tests to perform diagnosis of companion and food-producing animals. The reference laboratory accounted for the largest market share of the veterinary diagnostics market and is expected to grow at a higher CAGR in next five years. This large share for reference laboratories is due to the increased importance of having specialized centers to deal with the animal disease and to maintain a reference database for quick identification of any disease in animals.
North America is the largest regional segment for veterinary diagnostics owing to the well-established animal healthcare market. The largest share of this regional segment is driven by Increasing demand for animal-derived food products, rising companion animal healthcare expenditure, growing number of veterinary practitioners and their income levels, and rising awareness about zoonotic diseases. However, the market in the Asia-Pacific region is expected to grow at the highest CAGR, owing to rising pet adoption and increasing demand for animal-derived food products in India and China.
The market players, namely, IDEXX Laboratories, (U.S.), VCA, Inc. (U.S.), and ABAXIS, Inc. (U.S.) held the major share of the veterinary diagnostics market and will continue to dominate the market between 2016 and 2021. Other major players operating in this market are Heska Corporation (U.S.), Neogen Corporation (U.S.), Thermo fisher Scientific, Inc. (U.S.), Zoetis, Inc. (U.S.), ID.Vet (France), Virbac (France), Mindray Medical Internationals Ltd. (China), GE Healthcare (U.K.), and Agfa Healthcare (Netherlands).
MarketsandMarkets is the world’s No. 2 firm in terms of annually published premium market research reports. Serving 1700 global fortune enterprises with more than 1200 premium studies in a year, M&M is catering to a multitude of clients across 8 different industrial verticals. We specialize in consulting assignments and business research across high growth markets, cutting edge technologies and newer applications. Our 850 fulltime analyst and SMEs at MarketsandMarkets are tracking global high growth markets following the "Growth Engagement Model – GEM". The GEM aims at proactive collaboration with the clients to identify new opportunities, identify most important customers, write "Attack, avoid and defend" strategies, identify sources of incremental revenues for both the company and its competitors.
M&M’s flagship competitive intelligence and market research platform, "RT" connects over 200,000 markets and entire value chains for deeper understanding of the unmet insights along with market sizing and forecasts of niche markets. The new included chapters on Methodology and Benchmarking presented with high quality analytical infographics in our reports gives complete visibility of how the numbers have been arrived and defend the accuracy of the numbers.
We at MarketsandMarkets are inspired to help our clients grow by providing apt business insight with our huge market intelligence repository.
Markets and Markets
UNIT no 802, Tower no. 7, SEZ
Magarpatta city, Hadapsar
Pune, Maharashtra 411013, India